IC14 for Treatment of Amyotrophic Lateral Sclerosis
NCT03508453
·
clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class
Stopped
No participants enrolled in study
Conditions
Amyotrophic Lateral Sclerosis
Motor Neuron Disease
Interventions
BIOLOGICAL:
IC14
OTHER:
Placebo
Sponsor
Implicit Bioscience